All In Biotech

Drug Trial Radar · NCT00295854

Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Last checked: Nov 19, 2026Latest source record: Jan 19, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 296 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

296

Actual

Start

May 2005

Primary completion

Oct 2006

Study completion Oct 2006

Sponsor

Lead sponsor
MediciNovaIndustry
Sponsor type
Industry
First posted
Feb 24, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and efficacy of 8 weeks of treatment with MN-001 at 500 mg bid, 500 mg once daily vs. placebo in patients with Interstitial Cystitis.

Conditions

  • Interstitial Cystitis

Interventions

  • MN-001 BIDDrug

    Eligible patients received 500 mg MN-001 bid

  • MN-001Drug

    Eligible patients received 500 mg MN-001 once daily (qd)

  • PlaceboDrug

    Eligible patients received placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number Subjects at Least "Moderately Improved" for Each Treatment Group in Patient Reported Global Response Assessment (GRA)Time frame: 8 weeks

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • MediciNova Investigational Site

    Birmingham, Alabama

  • Citrus Valley Urological Medical Group

    Glendora, California

  • Atlantic Urological Medical Group

    Long Beach, California

  • Mendez Transplant and Urological Medical Group

    San Diego, California

  • Boulder Medical Center, P.C.

    Boulder, Colorado

  • Western Urologic Research Center

    Wheat Ridge, Colorado

  • Segal Institute for Clinical Research

    Aventura, Florida

  • Visions Clinical Research

    Boynton Beach, Florida

  • West Florida Urology

    Palm Harbor, Florida

  • Adult and Pediatric Urology

    Plantation, Florida

  • Georgis Patsias, MD., PA

    Wellington, Florida

  • Shepherd Center, Inc.

    Atlanta, Georgia

  • Center For Advanced Pelvic Surgery

    Centralia, Illinois

  • Evanston Continence Center

    Evanston, Illinois

  • Regional Urology, LLC

    Shreveport, Louisiana

  • William Beaumont Hospital

    Royal Oak, Michigan

  • Sheldon J. Freedman, MD, LTD

    Las Vegas, Nevada

  • Associated Urologic Specialists, P.A.

    Marlton, New Jersey

  • Upstate Urology

    Albany, New York

  • Lyndhurst Gynecology Associates

    Winston-Salem, North Carolina

  • Tristate Urologic Services PSC., Inc.

    Cincinnati, Ohio

  • Midwest Regional Center For Chronic Pelvic Pain and Bladder Control

    Lima, Ohio

  • Williamette Women's Healthcare P.C.

    Tualatin, Oregon

  • The Urology Group

    Greer, South Carolina

  • Medical Arts Clinic

    Corsicana, Texas

  • Gant Foundation

    Fort Worth, Texas

  • Brian Heaton, MD

    Ogden, Utah

  • Integrity Medical Research, LLC

    Mountlake Terrace, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.